{"filing":{"accession_number":"0001731122-26-001362","cik":"0001527728","ticker":"LNAI","company_name":"Lunai Bioworks Inc.","form":"8-K","filing_date":"2026-10-22","report_date":"2026-10-16","primary_document":"e8019_8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112226001362/e8019_8-k.htm"},"events":[{"id":37376,"run_id":34454,"accession_number":"0001731122-26-001362","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.97,"summary":"Lunai Bioworks received a Nasdaq determination on October 21, 2026, that it no longer complies with Listing Rule 5550(b)(1) due to a stockholders' deficit of $(9,024,946), failing to meet minimum equity requirements. The Company's Board approved voluntary withdrawal from Nasdaq listing on October 22, 2026, with trading suspension expected October 30, 2026, and delisting effective November 12, 2026.","company_name":"Lunai Bioworks Inc.","ticker":"LNAI","filing_date":"2026-10-22","form":"8-K","submitted_at":null,"items":[{"id":42068,"accession_number":"0001731122-26-001362","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Lunai Bioworks received a Nasdaq determination on October 21, 2026, that it no longer complies with Listing Rule 5550(b)(1) due to a stockholders' deficit of $(9,024,946), failing to meet minimum equity requirements of $2,500,000. The Company's Board approved voluntary withdrawal from Nasdaq listing on October 22, 2026, with trading suspension expected October 30, 2026, and delisting effective November 12, 2026. This is a terminal delisting event materially affecting the registrant's public market status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T10:04:05.870958+00:00","company_name":"","ticker":null,"filing_date":""},{"id":42069,"accession_number":"0001731122-26-001362","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors;","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that Lunai Bioworks received a Nasdaq determination on October 21, 2026, that the Company no longer complies with Nasdaq Listing Rule 5550(b)(1) due to stockholders' deficit of $(9,024,946), and that the Company's Board approved voluntary delisting and deregistration. Trading suspension is expected October 30, 2026, with delisting effective November 12, 2026. While the Item 5.02 section also reports the resignations of CFO Nathen Fuentes and Board member Douglas W. Calder, the central material event disclosed is the delisting determination and the Company's decision to voluntarily delist from Nasdaq and suspend SEC reporting obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T10:04:05.870958+00:00","company_name":"","ticker":null,"filing_date":""},{"id":42070,"accession_number":"0001731122-26-001362","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"Lunai Bioworks received a Nasdaq determination on October 21, 2026, that it no longer complies with Listing Rule 5550(b)(1) due to stockholders' deficit of $(9,024,946), triggering mandatory delisting. The Company's Board approved voluntary withdrawal from Nasdaq listing on October 22, 2026, with trading suspension expected October 30, 2026, and delisting effective on or about November 12, 2026. This is a material delisting event that fundamentally affects the registrant's public market status and investor access to the security.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T10:04:05.870958+00:00","company_name":"","ticker":null,"filing_date":""},{"id":42071,"accession_number":"0001731122-26-001362","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that Nasdaq determined the Company no longer complies with minimum stockholders' equity requirements (reporting a deficit of $(9,024,946)), resulting in a mandatory delisting determination. The Company's Board approved voluntary withdrawal from Nasdaq listing, with trading expected to suspend on October 30, 2026, and delisting to become effective on or about November 12, 2026. This is a material delisting event that directly threatens the Company's public market status and SEC reporting obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T10:04:05.870958+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":42068,"accession_number":"0001731122-26-001362","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Lunai Bioworks received a Nasdaq determination on October 21, 2026, that it no longer complies with Listing Rule 5550(b)(1) due to a stockholders' deficit of $(9,024,946), failing to meet minimum equity requirements of $2,500,000. The Company's Board approved voluntary withdrawal from Nasdaq listing on October 22, 2026, with trading suspension expected October 30, 2026, and delisting effective November 12, 2026. This is a terminal delisting event materially affecting the registrant's public market status.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T10:04:05.870958+00:00","company_name":"Lunai Bioworks Inc.","ticker":"LNAI","filing_date":"2026-10-22"},{"id":42069,"accession_number":"0001731122-26-001362","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors;","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that Lunai Bioworks received a Nasdaq determination on October 21, 2026, that the Company no longer complies with Nasdaq Listing Rule 5550(b)(1) due to stockholders' deficit of $(9,024,946), and that the Company's Board approved voluntary delisting and deregistration. Trading suspension is expected October 30, 2026, with delisting effective November 12, 2026. While the Item 5.02 section also reports the resignations of CFO Nathen Fuentes and Board member Douglas W. Calder, the central material event disclosed is the delisting determination and the Company's decision to voluntarily delist from Nasdaq and suspend SEC reporting obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T10:04:05.870958+00:00","company_name":"Lunai Bioworks Inc.","ticker":"LNAI","filing_date":"2026-10-22"},{"id":42070,"accession_number":"0001731122-26-001362","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"Lunai Bioworks received a Nasdaq determination on October 21, 2026, that it no longer complies with Listing Rule 5550(b)(1) due to stockholders' deficit of $(9,024,946), triggering mandatory delisting. The Company's Board approved voluntary withdrawal from Nasdaq listing on October 22, 2026, with trading suspension expected October 30, 2026, and delisting effective on or about November 12, 2026. This is a material delisting event that fundamentally affects the registrant's public market status and investor access to the security.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T10:04:05.870958+00:00","company_name":"Lunai Bioworks Inc.","ticker":"LNAI","filing_date":"2026-10-22"},{"id":42071,"accession_number":"0001731122-26-001362","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that Nasdaq determined the Company no longer complies with minimum stockholders' equity requirements (reporting a deficit of $(9,024,946)), resulting in a mandatory delisting determination. The Company's Board approved voluntary withdrawal from Nasdaq listing, with trading expected to suspend on October 30, 2026, and delisting to become effective on or about November 12, 2026. This is a material delisting event that directly threatens the Company's public market status and SEC reporting obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-23T10:04:05.870958+00:00","company_name":"Lunai Bioworks Inc.","ticker":"LNAI","filing_date":"2026-10-22"}]}